We are monitoring the impact of COVID-19 on Europe Plasma Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 207
Share on
Share on

Europe Plasma Protein Therapeutics Market Research Report – Segmented By Product Type, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 207
Pages: 132

Europe Plasma Protein Therapeutics Market Size (2021 to 2026)

The Plasma Protein Therapeutics Market size in Europe was estimated at USD 8762.44 Million in 2021. It is expected to reach USD 12868.94 Million by 2026, growing at a staggering CAGR of 7.99% between 2021 to 2026.

The usage of plasma proteins has increased significantly in medical applications owing to the new introductions in plasma-derived therapies. The advancements in technology have made the process of extracting protein from plasma more efficient and cost-saving and are aiding the growth of the market. According to WHO reports, more than half of the blood donors are from high-income nations, which accounts for 18% of the population. Government initiatives and increasing awareness regarding blood donations are believed to help the growth of the market.

Plasma is a protein-rich fluid that is responsible for blood clotting and providing immunity towards diseases. Isolation of these proteins from plasma can help provide medical therapies, which include immune deficiencies, autoimmune, neurological, and bleeding disorders. Plasma protein therapies help replace the deficient or missing proteins and help the individual lead a normal life. The therapies involve either the injection or infusion of biological medicines to treat life-threatening genetic and chronic diseases.

The market is driven by a host of factors, which include increased introduction of new plasma-derived therapies, rise in life-threatening diseases that involve immune and neurological systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Idiopathic thrombocytopenic purpura (ITP), and infectious diseases like Hepatitis A&B, Tetanus, Rabies, and varicella.

However, factors like stringent policies by the government and complexity in manufacturing the protein reimbursement must be taken care of for the market to prosper. 

This research report on the European Plasma Protein Therapeutics Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Immunoglobulins
  • Albumin
  • Coagulation Factor
  • Alpha-1 Proteinase Inhibitor
  • Others

By Application: 

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Major market participants in the European Plasma Protein Therapeutics Market are Grifols, CSL Behring, Baxter, Krdrion, China Biologics, Octapharma, Chendu Inst Shire Plc.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 U.K                                                                 

                6.3 Spain                                                                             

                6.4 Germany                                                                     

                6.5 Italy                                                                               

                6.6 France                                                                          

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  2. Europe Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  3. Europe Immunoglobulins Market, By Region, From 2021 to 2026 (USD Million)
  4. Europe Albumin Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Coagulation Factors Market, By Region, From 2021 to 2026 (USD Million)
  6. Europe Alpha-1 proteinase inhibitor Market, By Region, From 2021 to 2026 (USD Million)
  7. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Hemophilia Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Primary Immunodeficiency Disorder Market, By Region, From 2021 to 2026 (USD Million)
  10. Europe Idiopathic Thrombocytopenic Purpura Market, By Region, From 2021 to 2026 (USD Million)
  11. Europe Secondary Immunodeficiency Market, By Region, From 2021 to 2026 (USD Million)
  12. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  13. U.K Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  14. Spain Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  15. Germany Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  16. Italy Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  17. France Plasma Protein Therapeutics Market, By Type, From 2021 to 2026 (USD Million)
  18. U.K Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  19. Spain Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  20. Germany Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  21. Italy Plasma Protein Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  22. France Plasma Protein Therapeutics Market, By Application From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample